Erudio Healtherudio.com
Drug
Polatuzumab vedotin trials: what clinicians said in public
No HCP commentary report on a trial studying polatuzumab vedotin yet. Erudio has found public clinician commentary on 8 clinical trials studying polatuzumab vedotin, including LOTIS-7, POLARGO, POLARIX and SUNMO. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| POLARIX NCT03274492 · Hoffmann-La Roche DeepView → | previously untreated diffuse large B-cell lymphoma | Phase 3 | Deep | View | |||
| SUNMO NCT05171647 · Hoffmann-La Roche DeepView → | transplant-ineligible relapsed/refractory large B-cell lymphoma | Phase 3 | Deep | View | |||
| POLARGO NCT04182204 · Hoffmann-La Roche DeepView → | relapsed/refractory diffuse large B-cell lymphoma | Phase 3 | Deep | View | |||
| LOTIS-7 NCT04970901 · ADC Therapeutics S.A. DeepView → | relapsed or refractory B-cell non-Hodgkin lymphoma | Phase 1 | Deep | View | |||
| GO29365 NCT02257567 · Hoffmann-La Roche StandardView → | relapsed/refractory follicular or diffuse large B-cell lymphoma | Phase 1/Phase 2 | Standard | View | |||
| NCT03671018 NCT03671018 · Hoffmann-La Roche FocusedView → | relapsed or refractory B-cell non-Hodgkin lymphoma | Phase 1/Phase 2 | Focused | View | |||
| ROMULUS NCT01691898 · Genentech, Inc. FocusedView → | relapsed or refractory B-cell non-Hodgkin lymphoma | Phase 1/Phase 2 | Focused | View | |||
| NCT03677141 NCT03677141 · Hoffmann-La Roche FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||